283 related articles for article (PubMed ID: 36907201)
1. Thrombolysis for acute ischaemic stroke: current status and future perspectives.
Tsivgoulis G; Katsanos AH; Sandset EC; Turc G; Nguyen TN; Bivard A; Fischer U; Khatri P
Lancet Neurol; 2023 May; 22(5):418-429. PubMed ID: 36907201
[TBL] [Abstract][Full Text] [Related]
2. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
[TBL] [Abstract][Full Text] [Related]
3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
4. Advances in Acute Ischemic Stroke Therapy.
Xiong Y; Wakhloo AK; Fisher M
Circ Res; 2022 Apr; 130(8):1230-1251. PubMed ID: 35420919
[TBL] [Abstract][Full Text] [Related]
5. Treatments in Ischemic Stroke: Current and Future.
Mosconi MG; Paciaroni M
Eur Neurol; 2022; 85(5):349-366. PubMed ID: 35917794
[TBL] [Abstract][Full Text] [Related]
6. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
Menon BK; Buck BH; Singh N; Deschaintre Y; Almekhlafi MA; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar J; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra S; Gioia LC; Jalini S; Cayer C; Phillips S; Elamin E; Shoamanesh A; Subramaniam S; Kate M; Jacquin G; Camden MC; Benali F; Alhabli I; Bala F; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe A; Sehgal A; Zhang Q; Lethebe BC; Doram C; Ademola A; Shamy M; Kenney C; Sajobi TT; Swartz RH;
Lancet; 2022 Jul; 400(10347):161-169. PubMed ID: 35779553
[TBL] [Abstract][Full Text] [Related]
7. Novel thrombolytic drugs: will they make a difference in the treatment of ischaemic stroke?
Meretoja A; Tatlisumak T
CNS Drugs; 2008; 22(8):619-29. PubMed ID: 18601301
[TBL] [Abstract][Full Text] [Related]
8. Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit.
Bivard A; Zhao H; Coote S; Campbell B; Churilov L; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski A; Dos Santos A; Ng F; Langenberg F; Stephenson M; Smith K; Bernard S; Thijs V; Cloud G; Choi P; Ma H; Wijeratne T; Chen C; Olenko L; Davis SM; Donnan GA; Parsons M
BMJ Open; 2022 Apr; 12(4):e056573. PubMed ID: 35487712
[TBL] [Abstract][Full Text] [Related]
9. Thrombolytic strategies for ischemic stroke in the thrombectomy era.
Gauberti M; Martinez de Lizarrondo S; Vivien D
J Thromb Haemost; 2021 Jul; 19(7):1618-1628. PubMed ID: 33834615
[TBL] [Abstract][Full Text] [Related]
10. Femoral Access-Site Complications with Tenecteplase versus Alteplase before Mechanical Thrombectomy for Large-Vessel-Occlusion Stroke.
Hendrix P; Collins MK; Goren O; Weiner GM; Dalal SS; Melamed I; Kole MJ; Griessenauer CJ; Noto A; Schirmer CM
AJNR Am J Neuroradiol; 2023 Jun; 44(6):681-686. PubMed ID: 37169538
[TBL] [Abstract][Full Text] [Related]
11. Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study.
Teivane A; Jurjāns K; Vētra J; Grigorjeva J; Kupcs K; Masiliūnas R; Miglāne E
Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143846
[No Abstract] [Full Text] [Related]
12. Thrombolysis for acute ischaemic stroke with alteplase in an Asian population: results of the multicenter, multinational Safe Implementation of Thrombolysis in Stroke-Non-European Union World (SITS-NEW).
Rha JH; Shrivastava VP; Wang Y; Lee KE; Ahmed N; Bluhmki E; Hermansson K; Wahlgren N;
Int J Stroke; 2014 Oct; 9 Suppl A100():93-101. PubMed ID: 22988894
[TBL] [Abstract][Full Text] [Related]
13. Intravenous Thrombolysis for Acute Ischemic Stroke.
Grotta JC
Continuum (Minneap Minn); 2023 Apr; 29(2):425-442. PubMed ID: 37039403
[TBL] [Abstract][Full Text] [Related]
14. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
Zhong CS; Beharry J; Salazar D; Smith K; Withington S; Campbell BCV; Wilson D; Le Heron C; Mason D; Duncan R; Reimers J; Mein-Smith F; Diprose WK; Barber PA; Ranta A; Fink JN; Wu TY
Stroke; 2021 Mar; 52(3):1087-1090. PubMed ID: 33588597
[TBL] [Abstract][Full Text] [Related]
15. Repeated intravenous thrombolysis in early recurrent ischemic stroke: a case report of an elderly low weight female.
Chen F; Chen X; Zhang Q; Wen S; Zhou C
Neurol Sci; 2024 Jan; 45(1):345-348. PubMed ID: 37725194
[No Abstract] [Full Text] [Related]
16. Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis.
Mullen MT; Pisapia JM; Tilwa S; Messé SR; Stein SC
Stroke; 2012 Sep; 43(9):2350-5. PubMed ID: 22811451
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment.
Diener HC; Foerch C; Riess H; Röther J; Schroth G; Weber R
Lancet Neurol; 2013 Jul; 12(7):677-88. PubMed ID: 23726849
[TBL] [Abstract][Full Text] [Related]
18. Clinical potential of intra-arterial thrombolytic therapy in patients with acute ischaemic stroke.
Xavier AR; Siddiqui AM; Kirmani JF; Hanel RA; Yahia AM; Qureshi AI
CNS Drugs; 2003; 17(4):213-24. PubMed ID: 12665395
[TBL] [Abstract][Full Text] [Related]
19. Acute Treatment of Ischemic Stroke.
Lyden S; Wold J
Neurol Clin; 2022 Feb; 40(1):17-32. PubMed ID: 34798968
[TBL] [Abstract][Full Text] [Related]
20. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial.
Kvistad CE; Næss H; Helleberg BH; Idicula T; Hagberg G; Nordby LM; Jenssen KN; Tobro H; Rörholt DM; Kaur K; Eltoft A; Evensen K; Haasz J; Singaravel G; Fromm A; Thomassen L
Lancet Neurol; 2022 Jun; 21(6):511-519. PubMed ID: 35525250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
